This inventor holds 2 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1994-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1995
Title: Kozo Ishida: Innovator in Pharmaceutical Composition
Introduction
Kozo Ishida is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of highly absorbable compositions. With a total of 2 patents to his name, Ishida's work is recognized for its innovative approach to drug formulation.
Latest Patents
Ishida's latest patents include a highly absorbable pharmaceutical composition. This composition contains, as the active ingredient, methyl 3-phenyl-2(E)-propenyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate in an amorphous state. It also features a pH-dependent type copolymer of methacrylic acid or its derivatives. The composition is prepared by dissolving the two components together in an organic solvent and subsequently removing the solvent. Another patent involves a particulate preparation containing a flourracil derivative.
Career Highlights
Kozo Ishida is currently associated with Otsuka Pharmaceutical Company, Limited. His work at this esteemed organization has allowed him to focus on innovative pharmaceutical solutions that address various medical needs. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Ishida has collaborated with notable colleagues, including Yoshihiro Ishizue and Toru Nishibayashi. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical sector.
Conclusion
Kozo Ishida's contributions to pharmaceutical innovation are commendable. His patents reflect a commitment to improving drug formulations and enhancing patient outcomes. His work continues to influence the field of pharmaceuticals positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
